-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Amy Weaver
-
Issuer symbol
-
CRM
-
Transactions as of
-
22 Jan 2024
-
Net transactions value
-
-$782,533
-
Form type
-
4
-
Filing time
-
23 Jan 2024, 20:58:45 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRM |
Common Stock |
Options Exercise |
$0 |
+1,014 |
+2.7% |
$0.000000 |
38,993 |
22 Jan 2024 |
Direct |
|
| transaction |
CRM |
Common Stock |
Options Exercise |
$404,926 |
+2,627 |
+6.7% |
$154.14 |
41,620 |
22 Jan 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$472,944 |
+2,198 |
+5.3% |
$215.17 |
43,818 |
22 Jan 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$490,754 |
+2,249 |
+5.1% |
$218.21 |
46,067 |
22 Jan 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Sale |
$2,009,016 |
-7,074 |
-15% |
$284.00 |
38,993 |
22 Jan 2024 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Sale |
$142,141 |
-510 |
-1.3% |
$278.71 |
38,483 |
23 Jan 2024 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRM |
Restricted Stock Units |
Options Exercise |
$0 |
-1,014 |
-50% |
$0.000000 |
1,014 |
22 Jan 2024 |
Common Stock |
1,014 |
$0.000000 |
Direct |
F3, F4 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,627 |
-25% |
$0.000000 |
7,883 |
22 Jan 2024 |
Common Stock |
2,627 |
$154.14 |
Direct |
F5 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,198 |
-6.7% |
$0.000000 |
30,774 |
22 Jan 2024 |
Common Stock |
2,198 |
$215.17 |
Direct |
F6 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,249 |
-3.7% |
$0.000000 |
58,474 |
22 Jan 2024 |
Common Stock |
2,249 |
$218.21 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: